Methods Evaluated for Autoimmune Hemolytic Anemia Diagnosis
By LabMedica International staff writers Posted on 21 Jun 2012 |
The use of both the gel test (GT) and flow cytometry (FC) techniques in the detection of red blood cell-bound immunoglobulin G (IgG) has been assessed.
The two tests are important in the diagnosis of autoimmune hemolytic anemia (AIHA) in cases that were negative by the conventional tube technique (CTT) or direct antiglobulin test (DAT).
Hematologists at Ain Shams University (Cairo, Egypt) conducted a case-control study between August 2008 and October 2010. The study included 50 patients, who were clinically diagnosed to have Warm Antibody AIHA with negative CTT-DAT. Fifty-five healthy volunteers with negative polyspecific CTT-DAT were also enrolled as control subjects.
Blood samples were tested by the Direct Antiglobulin Test by CTT and GT and by FC technique. In the FC assay, the results were expressed as percent fluorescence, which is the percentage of erythrocytes expressing the anti-human IgG at levels above those of the isotype control, and mean fluorescence intensity (MFI). For the GT assay, a positive test is where agglutinated cells formed a red line on gel surface or dispersed agglutinates in the gel and were graded from G1-G4. For the CTT, agglutination was detected macroscopically and confirmed by microscopic examination.
The results of the study showed that 46 of 50 (92%) patients were positive by GT. The Receiver Operating Characteristic curve for FC assay determined that a cut-off of 17.5% fluorescence was the best value for interpreting FC-DAT positively in the group of patients with hemolytic anemia, with 100% sensitivity and specificity. The best cut-off for MFI was 1.74, with 76% specificity and 96% sensitivity. Both mean percent fluorescence and MFI were significantly higher among patients when compared to controls. The FC assay was performed using the Coulter Epics XL 3-colour flow cytometer (Beckman Coulter Inc., Brea, CA, USA).
The authors concluded that GT and FC are sensitive tools for assessing CTT-DAT-negative AIHA. However, FC is more precise and so should be utilized when a strong clinical suspicion of AIHA is associated with dissonant CTT and GT results. They propose that FC percent fluorescence cut-off values should be employed to determine the Coombs’ negative AIHA cases. However, they do imply that larger studies are needed to define the best cut-off value for FC IgG DAT positivity in such cases. The study was published in the June 2012 issue of the International Journal of Laboratory Hematology.
Related Links:
Ain Shams University
Beckman Coulter Inc.
The two tests are important in the diagnosis of autoimmune hemolytic anemia (AIHA) in cases that were negative by the conventional tube technique (CTT) or direct antiglobulin test (DAT).
Hematologists at Ain Shams University (Cairo, Egypt) conducted a case-control study between August 2008 and October 2010. The study included 50 patients, who were clinically diagnosed to have Warm Antibody AIHA with negative CTT-DAT. Fifty-five healthy volunteers with negative polyspecific CTT-DAT were also enrolled as control subjects.
Blood samples were tested by the Direct Antiglobulin Test by CTT and GT and by FC technique. In the FC assay, the results were expressed as percent fluorescence, which is the percentage of erythrocytes expressing the anti-human IgG at levels above those of the isotype control, and mean fluorescence intensity (MFI). For the GT assay, a positive test is where agglutinated cells formed a red line on gel surface or dispersed agglutinates in the gel and were graded from G1-G4. For the CTT, agglutination was detected macroscopically and confirmed by microscopic examination.
The results of the study showed that 46 of 50 (92%) patients were positive by GT. The Receiver Operating Characteristic curve for FC assay determined that a cut-off of 17.5% fluorescence was the best value for interpreting FC-DAT positively in the group of patients with hemolytic anemia, with 100% sensitivity and specificity. The best cut-off for MFI was 1.74, with 76% specificity and 96% sensitivity. Both mean percent fluorescence and MFI were significantly higher among patients when compared to controls. The FC assay was performed using the Coulter Epics XL 3-colour flow cytometer (Beckman Coulter Inc., Brea, CA, USA).
The authors concluded that GT and FC are sensitive tools for assessing CTT-DAT-negative AIHA. However, FC is more precise and so should be utilized when a strong clinical suspicion of AIHA is associated with dissonant CTT and GT results. They propose that FC percent fluorescence cut-off values should be employed to determine the Coombs’ negative AIHA cases. However, they do imply that larger studies are needed to define the best cut-off value for FC IgG DAT positivity in such cases. The study was published in the June 2012 issue of the International Journal of Laboratory Hematology.
Related Links:
Ain Shams University
Beckman Coulter Inc.
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
RNA Blood Test Detects Cancers and Resistance to Treatment
A newly developed blood test offers the ability to detect cancer, understand how cancer resists treatments, and assess tissue damage from non-cancerous conditions. This innovative test, created by researchers... Read more
IL-6 Outperforms Traditional Tests for Early Sepsis Detection
Sepsis, a severe and life-threatening condition caused by the immune system’s exaggerated response to infection, remains a major cause of death globally, responsible for approximately 11 million fatalities... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read more
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more